ITI News Archive

The 22-year-old patient had waited years for an intestinal transplant. At Stanford Medicine, a combined intestinal and abdominal wall transplant gave him an even better option.

Stanford Medicine researchers have shown that prior SARS-CoV-2 infection reduces killer T cells’ response to vaccination. These cells are crucial for eliminating the virus from the body.

A connection found between asthma, eczema and osteoarthritis indicates that drugs to treat allergic conditions could be used in future studies aimed at slowing the progression of osteoarthritis.

A novel Stanford School of Medicine partnership uncovers a direct link between a cancer-associated gene, Myc, and sugar patterns on cancer cell surfaces that tell immune cells to stand down.

Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.

Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.

A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.

The California Institute for Regenerative Medicine has funded Stanford Medicine projects to improve kidney transplantation and advance treatment for a rare genetic disease in children.

In a trial led by Stanford Medicine researchers, more than half of patients with persistent smell loss saw improvement with injections of platelet-rich plasma.

A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.